Importance of Coronavirus Disease 2019 Vaccination in Children: Viewpoint and Recommendations of the Union of European National Societies of Pediatrics - 24/03/22
Doi : 10.1016/j.jpeds.2021.12.066
Massimo Pettoello-Mantovani, MD, PhD 1, 2, 3, 4, Cristina Cardemil, MD, MPH 5, Robert Cohen, MD 6, 7, 8, Corinne Levy, MD 6, 7, 8, Ida Giardino, MD 9, Flavia Indrio, MD 4, Eli Somekh, MD 1, 2, 10, 11
1 European Paediatric Association/Union of National European Paediatric Societies and Associations (EPA/UNEPSA), Berlin, Germany
2 Association pour l’Activité et la Recherche Scìentifiques, ARS, Nouchatel, Switzerland
3 Italian Academy of Pediatrics, Milan, Italy
4 Department of Pediatrics, University of Foggia, “Casa Sollievo” Scientific Institute, San Giovanni Rotondo, Italy
5 Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Rockville, MD
6 Pediatric Infectious Disease Group (GPIP), Créteil, France
7 Association Clinique et thérapeutique Infantile du Val de Marne, Créteil, France
8 Paris Est University, IMRB-GRC GEMINI, Créteil, France
9 Department of Biomedical Sciences, University of Foggia, Foggia, Italy
10 Department of Pediatrics, Mayanei Hayeshuah Medical Center, Bnei Brak, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
11 Israel Pediatric Society, Tel Aviv, Israel
Bienvenue sur EM-consulte, la référence des professionnels de santé.
Article gratuit.
Connectez-vous pour en bénéficier!
Keyword : COVID-19, EMA, EPA-UNEPSA, EU, FDA, MIS-C, SARS-CoV-2
Le texte complet de cet article est disponible en PDF.
Plan
| The authors declare no conflict of interest. The opinions expressed by CC in this article are those of the author and do not represent the official views of the U.S. Department of Health and Human Services, National Institutes of Health, or National Institute of Allergy and Infectious Diseases. |
© 2021
Elsevier Inc. Tous droits réservés.
Vol 243
P. 242-245 - avril 2022 Retour au numéro
Article précédent
- 50 Years Ago in The Journal of Pediatrics : The Development of the Rubella Vaccine and Joint Adverse Events
- Limor Ashkenazi, Philip J. Hashkes
Bienvenue sur EM-consulte, la référence des professionnels de santé.